商铺首页
公司详情
产品陈列室
联系方式
基本信息
企业名称
江苏阿尔法药业股份有限公司
企业地址
江苏宿迁生态化工科技产业园燕山路5号
成立日期
2007
企业规模(人)
500以上
年销售额(USD)
不愿意公开
企业简介
江苏阿尔法药业集团总部位于淮海经济区中心城市—江苏省宿迁市,是一家从事高级医药中间体、医药原料药、化学制剂、生物酶、生物发酵、生物药品的综合性制药集团。公司从事预防性用药、慢性用药、重大疾病等大宗药物的研发、生产及销售,致力于高端仿制药、改良型创新药、原创药,在心脑血管、抗病毒、精神系统、肿瘤治疗等领域建立起具有全球竞争优势的产品管线。公司在他汀类降血脂药物领域产业根基扎实,占据市场龙头地位,在业内享有“他汀专家工厂”的美誉。恩格列净、达格列净、阿托伐他汀、瑞舒伐他汀、匹伐他汀、阿比特龙、依鲁替尼、利格列汀、索弗布韦、依折麦布、达比加群、孟鲁斯特及其他药物中间体。
主要竞争优势
经验丰富的研发人员,生产能力,产品线丰富,接受买家的规格要求,接受小额订单,良好的信誉,优质服务
邮政编码
223809
其他竞争优势
高科技产品;
贸易信息
业务类型
制造商,出口商
主要销售市场
西欧,东欧,亚洲
主营产品类别
中间体
产品外销比重
%
产品内销比重
%
主要客户名称
参展信息
主营产品
Empagliflozin Intermediates;Dapagliflozin Intermediates;Atorvastatin Intermediates;Rosuvastatin Intermediates;Pitavastatin Intermediates;Abiraterone intermediate;Ibrutinib intermediate;Linagliptin, Alogliptin intermediate;Sofosbuvir Intermediates;Ezetimibe Intermediates;Dabigatran Intermediates;Montelukast Intermediates;3-Pyridyldiethylborane CAS NO:89878-14-8;(S)-1-Boc-3-hydroxypiperidine CAS NO:143900-44-1;(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran CAS NO:915095-89-5;Methoxydiethylborane in THF(CAS NO:7397-46-8);(R)-(+)-4-chloro 3-hydroxybutyronitrile(CAS NO:84367-31-7);3-Pyridyldiethylborane (CAS NO:89878-14-8);(S)-1-Boc-3-hydroxypiperidine (CAS NO:143900-44-1);(R)-3-aminopiperidine dihydrochloride (CAS NO:334618-23-4);(R)-3-(Boc-Amino)piperidine (CAS NO:309956-78-3);(S)-(+)-3-Hydroxytetrahydrofuran (CAS NO:86087-23-2);(S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone(CAS NO:915095-87-3);(5-bromo-2-chlorophenyl)-[4-[(3S)-oxolan-3-yl]oxyphenyl]methanone(CAS NO:915095-84-0);(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran(CAS NO:915095-94-2);(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran(CAS NO:915095-89-5);(3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethyl)oxan-2-one(CAS NO:32384-65-9);(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol tetraacetate(CAS NO:915095-99-7);5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone(CAS NO:461432-22-4);5-bromo-2-chloro-4'-ethoxydiphenylmethane(CAS NO:461432-23-5);(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate(CAS NO:461432-25-7);tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate(CAS NO:125971-94-0);tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate(CAS NO:125995-13-3);tert-butyl 2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate(CAS NO:125971-95-1);tert-butyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate(CAS NO:134395-00-9);Atorvastatin Calcium(CAS NO:134523-03-8);N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide(CAS NO:147118-36-3);5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine(CAS NO:799842-07-2);N-(4-(4-fluorophenyl)-5-formyl-6-isopropylpyrimidin-2-yl)-N-methyl- methanesulfonamide(CAS NO:147118-37-4);N-(5-((diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)- N-methylmethanesulfonamide(CAS NO:289042-10-0);Phosphonium, [[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]me(CAS NO:885477-83-8);tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3- dioxan-4-yl)- acetate(CAS NO:154026-94-5);tert-butyl 2-((4R,6S)-6-(acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4- yl)acetate(CAS NO:154026-95-6);tert-butyl 2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3- dioxan-4-yl) acetate(CAS NO:124655-09-0);tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate(CAS NO:124752-23-4);tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl (methylsulfonyl) amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3- dioxane-4-acetate(CAS NO:289042-12-2);tert-Butyl rosuvastatin(CAS NO:355806-00-7);Rosuvastatin Calcium(CAS NO:147098-20-2);(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol(CAS NO:121660-11-5);3-(Bromomethyl)-2-cyclopropyl-4-(4'-fluorophenyl)quinoline(CAS NO:154057-56-4);2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde(CAS NO:121660-37-5);((2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)diphenylphosphine oxide(CAS NO:146578-99-6);[2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido(CAS NO:154057-58-6);tert-butyl2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate(CAS NO:147489-06-3);tert-butyl(3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate(CAS NO:586966-54-3);Pitavastatin calcium(CAS NO:147526-32-7);isopropyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate(CAS NO:1334513-02-8);(2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate(CAS NO:817204-32-3);2'-deoxy-2'-fluoro-2'-C-methyluridine(CAS NO:863329-66-2);(S)-1-(4-fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5- dione(CAS NO:189028-93-1);(S)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2 -one(CAS NO:189028-95-3);(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one(CAS NO:272778-12-8);N-(4-cyanophenyl)-Glycine(CAS NO:42288-26-6);ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate(CAS NO:212322-56-0);ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)- 1-methyl-N-(pyridin-2-yl)- 1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride(CAS NO:211914-50-0);2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol(CAS NO:142569-70-8)or(CAS NO:287930-77-2)
参展展会
第二十三届世界制药原料中国展
展会时间
2025-03-06至2025-07-31
展位号
E7P20
展品分类
Intermediates & Fine Chemicals
参展信息
×